RhumbLine Advisers’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.24M Buy
122,110
+3,187
+3% +$60.6K ﹤0.01% 1788
2025
Q4
$1.87M Sell
118,923
-5,363
-4% -$95.7K ﹤0.01% 1900
2025
Q3
$2.41M Buy
124,286
+5,167
+4% +$101K ﹤0.01% 1805
2025
Q2
$2.46M Buy
119,119
+5,135
+5% +$107K ﹤0.01% 1778
2025
Q1
$2.79M Buy
113,984
+347
+0.3% +$8.91K ﹤0.01% 1646
2024
Q4
$2.72M Buy
113,637
+3,557
+3% +$113K ﹤0.01% 1728
2024
Q3
$4.67M Sell
110,080
-1,540
-1% -$80.8K ﹤0.01% 1462
2024
Q2
$5.72M Sell
111,620
-499
-0.4% -$28.3K 0.01% 1317
2024
Q1
$7.01M Sell
112,119
-1,409
-1% -$95.9K 0.01% 1238
2023
Q4
$8.5M Sell
113,528
-1,842
-2% -$132K 0.01% 1138
2023
Q3
$9.83M Sell
115,370
-2,127
-2% -$202K 0.01% 1000
2023
Q2
$12.8M Sell
117,497
-8,349
-7% -$791K 0.01% 889
2023
Q1
$10.4M Buy
125,846
+5,936
+5% +$559K 0.01% 942
2022
Q4
$12.3M Buy
119,910
+2,208
+2% +$254K 0.02% 830
2022
Q3
$12.5M Buy
117,702
+1,339
+1% +$147K 0.02% 776
2022
Q2
$12.8M Buy
116,363
+408
+0.4% +$40.4K 0.02% 780
2022
Q1
$12.1M Buy
115,955
+8,046
+7% +$835K 0.02% 860
2021
Q4
$13.2M Sell
107,909
-4,021
-4% -$446K 0.02% 829
2021
Q3
$12.8M Sell
111,930
-19,261
-15% -$2.04M 0.02% 818
2021
Q2
$12.7M Sell
131,191
-2,847
-2% -$247K 0.02% 866
2021
Q1
$9.88M Sell
134,038
-789
-0.6% -$58.6K 0.01% 998
2020
Q4
$9.2M Buy
134,827
+7,356
+6% +$480K 0.01% 974
2020
Q3
$7.45M Sell
127,471
-16,793
-12% -$884K 0.01% 922
2020
Q2
$6.53M Sell
144,264
-4,544
-3% -$217K 0.01% 1038
2020
Q1
$8.6M Sell
148,808
-843
-0.6% -$57.7K 0.02% 726
2019
Q4
$9.32M Buy
149,651
+10,460
+8% +$619K 0.02% 872
2019
Q3
$8.01M Sell
139,191
-129
-0.1% -$7.14K 0.01% 908
2019
Q2
$7.56M Buy
139,320
+5,422
+4% +$275K 0.01% 944
2019
Q1
$6.3M Buy
133,898
+1,128
+0.8% +$62.5K 0.01% 1041
2018
Q4
$7.52M Buy
132,770
+23,315
+21% +$1.31M 0.02% 864
2018
Q3
$5.99M Sell
109,455
-4,046
-4% -$232K 0.01% 991
2018
Q2
$6.65M Buy
113,501
+2,992
+3% +$179K 0.01% 914
2018
Q1
$6.27M Buy
110,509
+2,247
+2% +$122K 0.01% 905
2017
Q4
$5.33M Buy
108,262
+15,468
+17% +$705K 0.01% 1029
2017
Q3
$4.24M Buy
92,794
+2,180
+2% +$83.3K 0.01% 1136
2017
Q2
$3.54M Sell
90,614
-2,375
-3% -$91.1K 0.01% 1215
2017
Q1
$3.77M Buy
92,989
+26,418
+40% +$1.03M 0.01% 1181
2016
Q4
$2.56M Buy
66,571
+2,423
+4% +$82.8K 0.01% 1305
2016
Q3
$2.04M Buy
64,148
+4,573
+8% +$174K 0.01% 1381
2016
Q2
$2.38M Buy
59,575
+1,271
+2% +$47K 0.01% 1231
2016
Q1
$1.96M Buy
58,304
+1,425
+3% +$40.7K 0.01% 1396
2015
Q4
$1.77M Buy
56,879
+4,925
+9% +$146K 0.01% 1438
2015
Q3
$1.56M Buy
51,954
+1,140
+2% +$37.6K 0.01% 1487
2015
Q2
$1.6M Sell
50,814
-19,135
-27% -$500K 0.01% 1555
2015
Q1
$1.61M Buy
69,949
+1,300
+2% +$26.9K ﹤0.01% 1539
2014
Q4
$1.35M Buy
68,649
+1,391
+2% +$23.9K ﹤0.01% 1607
2014
Q3
$1.06M Buy
67,258
+1,450
+2% +$20.7K ﹤0.01% 1725
2014
Q2
$809K Buy
65,808
+16,942
+35% +$203K ﹤0.01% 1969
2014
Q1
$671K Sell
48,866
-2,250
-4% -$32.4K ﹤0.01% 2034
2013
Q4
$751K Sell
51,116
-580
-1% -$7.85K ﹤0.01% 1999
2013
Q3
$711K Sell
51,696
-589
-1% -$8.66K ﹤0.01% 1992
2013
Q2
$749K Buy
+52,285
New +$734K ﹤0.01% 1955

Other funds holding AMN

RhumbLine Advisers's AMN Position: Q1 2026 in Review

RhumbLine Advisers increased its AMN Healthcare (AMN) stake by 2.7% in Q1 2026, buying an estimated $60.6K and bringing the position to 122,110 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1788.

RhumbLine Advisers first reported a position in AMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.2M in Q4 2021. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • RhumbLine Advisers held 122,110 shares of AMN Healthcare worth $2.24M as of Q1 2026.
  • RhumbLine Advisers bought 3,187 AMN Healthcare shares in Q1 2026, an estimated $60.6K.
  • AMN Healthcare made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1788 holding.
  • RhumbLine Advisers first reported a position in AMN Healthcare in Q2 2013 and has held it in 52 quarters since.
  • RhumbLine Advisers's AMN Healthcare position peaked at $13.2M in Q4 2021.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.